Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Indonesia Acts to Override Patents on HIV Drugs
FDAnews Drug Daily Bulletin
Oct. 15, 2012
| Vol. 9 No. 202
Indonesia Acts to Override Patents on HIV Drugs
Indonesia’s government has taken steps to override patents on a range of HIV drugs, highlighting a growing trend by Asian states to allow local production of cheap generic drugs that cut into sales of global pharmaceutical companies.
Chicago Tribune
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Full Issue
Correction
Astellas Scraps EU Marketing Plans for Kidney Cancer Candidate
Merck Ends Trials For Once-Promising Parkinson’s Drug